More than 40% of men with intermediate-risk or high-risk prostate cancer will experience a
biochemical recurrence after radical prostatectomy. Clinical guidelines for the management …

Purpose Numerous publications during the COVID-19 pandemic recommended the use of
hypofractionated radiation therapy. This project assessed aggregate changes in the quality …

Purpose During a global pandemic, the benefit of routine visits and treatment of patients with
cancer must be weighed against the risks to patients, staff, and society. Prostate cancer is …

Purpose Postoperative radiation therapy (RT) is an underused standard-of-care intervention
for patients with prostate cancer and recurrence/adverse pathologic features after radical …

Simple Summary Stereotactic body radiotherapy, a type of high-precision radiotherapy
delivering high doses within few treatment sessions has proven to be effective and well …

Up to 50% of patients treated with radical surgery for localized prostate cancer may
experience biochemical recurrence that requires appropriate management. Definitions of …

Purpose Around 40% of men with intermediate-risk or high-risk prostate cancer will
experience a biochemical recurrence after radical prostatectomy (RP). The aim of this review …

Simple Summary Geometric variations of patients receiving stereotactic body radiotherapy
(SBRT) after radical prostatectomy were evaluated in this study. With specific bladder filling …

Objectives To assess the effectiveness and safety of HYPO-SRT in patients with biochemical
recurrence after radical prostatectomy, we performed a cohort study followed by meta …

Purpose To adapt the management of prostate malignancy in response to the COVID-19
pandemic. Methods In according to the recommendations of the European Association of …